+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Menopause Market - Global Forecast 2026-2032- Product Image
Menopause Market - Global Forecast 2026-2032- Product Image
New

Menopause Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454968
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The menopause market is seeing rapid transformation, driven by convergence in clinical innovation, evolving care pathways, and realignment of commercial and supply strategies. Senior decision-makers require clear, actionable insights to navigate these shifts and capitalize on emerging opportunities within menopause therapeutics.

Market Snapshot

The Menopause Market is projected for steady expansion, having grown from USD 490.15 billion in 2025 to USD 509.91 billion in 2026. It is set to continue at a CAGR of 5.40%, reaching USD 708.67 billion by 2032. This growth is underpinned by advances in both hormone replacement and non-hormonal therapies, the rising significance of supply chain resilience, and strategic segmentation along clinical and commercial touchpoints.

Scope & Segmentation

  • Therapeutic Classes: Includes hormone replacement therapies by formulation, selective antidepressants, neuromodulatory agents, botanical supplements, and symptomatic adjuncts.
  • Patient Stages: Spans perimenopause through postmenopause, aligned with symptom heterogeneity and care needs.
  • Routes of Administration: Oral (enteral), injectable (parenteral), and topical delivery, each shaping adherence and outcomes.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, online pharmacy/eCommerce platforms, and direct-to-patient models.
  • Regional Markets: Americas, Europe, Middle East & Africa, and Asia-Pacific, each defined by unique regulatory, clinical, and commercial dynamics.
  • Technology Adoption: Integration of telehealth, digital patient support programs, and pragmatic digital tools for adherence and fulfillment.

Key Takeaways

  • Patient segmentation is essential across clinical development and commercialization, supporting tailored evidence generation and optimized messaging strategies.
  • Supply chain adaptation remains critical as global trade measures and tariffs necessitate supplier diversification and geographic footprint review.
  • Digital health and omnichannel logistics are now established, connecting telemedicine, online fulfillment, and traditional pharmacy channels to improve access and adherence.
  • Clinical strategies must balance efficacy, long-term safety, and comorbidity management, with decisions increasingly aligned to patient-reported outcomes and real-world evidence.
  • Regional regulatory environments drive varying commercialization pathways, requiring tailored strategies in evidence development and payer engagement.

Tariff Impact

Recent United States tariff measures have significantly affected upstream sourcing and production costs in menopause therapeutics. Companies have responded by localizing manufacturing, developing multi-supplier partnerships, and optimizing logistics to protect margins and maintain supply continuity. These measures are reshaping negotiations across the value chain and incentivizing strategic investment in regionalized production.

Methodology & Data Sources

This report employs a robust mixed-methods framework, integrating primary interviews with clinicians, pharmacists, payers, supply chain experts, and patient advocates alongside systematic analysis of clinical literature and regulatory guidance. Operational insights are supplemented by case-level supply chain assessments and digital distribution pilots, ensuring findings support practical, board-level decisions.

Why This Report Matters

  • Enables executives to align clinical innovation with patient-centered delivery and evolving reimbursement models.
  • Identifies operational and sourcing responses to trade volatility, providing a blueprint for supply chain resilience and cost management.
  • Clarifies regional and channel-specific strategies, empowering granular commercialization and risk mitigation planning.

Conclusion

The menopause market’s evolution demands integrated approaches across clinical, operational, and commercial domains. Leaders who adopt segmentation-driven, supply-resilient, and omnichannel strategies will secure sustained value for both patients and stakeholders as the market continues to transform.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Menopause Market, by Product Type
8.1. Hormone Replacement Therapy (HRT)
8.1.1. Combined Estrogen-Progesterone Therapy
8.1.2. Estrogen Therapy
8.1.3. Progesterone Therapy
8.2. Non-Hormonal Treatments
8.2.1. Antidepressants
8.2.1.1. Citalopram
8.2.1.2. Escitalopram
8.2.1.3. Fluoxetine
8.2.2. Botanical Supplements
8.2.3. Gabapentin
8.2.4. Pregabalin
9. Menopause Market, by Stage of Menopause
9.1. Menopause
9.2. Perimenopause
9.3. Postmenopause
10. Menopause Market, by Route of Administration
10.1. Enteral
10.2. Parenteral
10.3. Topical
11. Menopause Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.2.1. Company Websites
11.2.2. eCommerce Platforms
11.3. Retail Pharmacies
12. Menopause Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Menopause Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Menopause Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Menopause Market
16. China Menopause Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Abbvie Inc.
17.7. Amgen Inc.
17.8. Apotex Inc.
17.9. Astellas Pharma Inc.
17.10. AstraZeneca PLC
17.11. Bayer AG
17.12. Cipla Ltd.
17.13. Eli Lilly and Company
17.14. Ferring International Center S.A.
17.15. Fervent Pharmaceuticals, LLC
17.16. Gedeon Richter PLC
17.17. GlaxoSmithKline PLC
17.18. Glenmark Pharmaceuticals Ltd.
17.19. Ipsen Group
17.20. Merck & Co.Inc.
17.21. Mithra Pharmaceuticals S.A.
17.22. Novartis AG
17.23. Novo Nordisk A/S
17.24. Organon & Co
17.25. Pfizer Inc.
17.26. Sun Pharmaceutical Industries Ltd.
17.27. Teva Pharmaceutical Industries Ltd.
17.28. TherapeuticsMD Inc.
17.29. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL MENOPAUSE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES MENOPAUSE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA MENOPAUSE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MENOPAUSE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS MENOPAUSE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 83. AMERICAS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 116. EUROPE MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 119. EUROPE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. EUROPE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 134. AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 137. AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 138. AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 139. AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 140. AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL MENOPAUSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 156. ASEAN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 157. ASEAN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 158. ASEAN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 159. ASEAN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 160. ASEAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. ASEAN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 162. GCC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GCC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 165. GCC MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 166. GCC MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 167. GCC MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 168. GCC MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 169. GCC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. GCC MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 180. BRICS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. BRICS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRICS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 183. BRICS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 184. BRICS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 185. BRICS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 186. BRICS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 187. BRICS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. BRICS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 189. G7 MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. G7 MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 192. G7 MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 193. G7 MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 194. G7 MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 195. G7 MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. G7 MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. G7 MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 198. NATO MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. NATO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 201. NATO MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 202. NATO MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 203. NATO MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 204. NATO MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. NATO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. NATO MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES MENOPAUSE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 217. CHINA MENOPAUSE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. CHINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2032 (USD MILLION)
TABLE 220. CHINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 221. CHINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2032 (USD MILLION)
TABLE 222. CHINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2032 (USD MILLION)
TABLE 223. CHINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 224. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. CHINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Menopause market report include:
  • Abbott Laboratories
  • Abbvie Inc.
  • Amgen Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Cipla Ltd.
  • Eli Lilly and Company
  • Ferring International Center S.A.
  • Fervent Pharmaceuticals, LLC
  • Gedeon Richter PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Ipsen Group
  • Merck & Co.Inc.
  • Mithra Pharmaceuticals S.A.
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 509.91 Billion
Forecasted Market Value ( USD ) by 2032 $ 708.67 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Menopause Market Outlook, 2030 - Product Image

Menopause Market Outlook, 2030

  • Report
  • 204 Pages
  • Global
From
Menopause Market - Product Image

Menopause Market

  • Report
  • 91 Pages
  • Global
From
Menopause Associated Vasomotor Symptoms Epidemiology Forecast 2025-2034 - Product Image

Menopause Associated Vasomotor Symptoms Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Menopause Supplement Global Market Report 2025 - Product Image

Menopause Supplement Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Menopause Market Report 2025 - Product Image

Menopause Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Menopause Market

The Menopause market is a subset of the Women's Health industry, focusing on the physical and emotional changes experienced by women during the transition from reproductive to non-reproductive years. It includes products and services that help women manage the symptoms of menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness. It also includes treatments for conditions associated with menopause, such as osteoporosis, heart disease, and urinary incontinence. The Menopause market is a growing industry, with an increasing number of products and services available to women. Companies in the market include pharmaceutical companies, health care providers, and wellness companies. Examples include Hormone Health Network, Menopause Solutions, and Menopause Support. Additionally, there are a number of online resources and support groups available to women going through menopause. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.